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Introduction
Macroautophagy, which is usually referred to as autophagy, is 
responsible for degradation of the majority of intracellular pro-
teins in mammalian cells, particularly during starvation-induced 
proteolysis. Cytosolic proteins, organelles, and selected regions 
of the nucleus can be cleared by autophagy to ensure cellular 
homeostasis and remove damaged or unwanted products 
(Klionsky, 2005). Cytoplasmic constituents are fi  rst enclosed 
by a double-membrane autophagosome; next, the outer mem-
brane of the autophagosome fuses with the lysosome, with the 
consequent destruction of the cargo and the inner membrane of 
the autophagosome by hydrolytic enzymes.
The autophagic pathway has been dissected at the mo-
lecular level in yeast, in which 27 genes, referred to as ATG, 
have been found to be required for autophagosome formation 
(Klionsky and Ohsumi, 1999; Yorimitsu and Klionsky, 2005). 
Two ubiquitin-like conjugation systems are involved in the 
 process: one mediates the covalent attachment of Atg12 to Atg5, 
and the other mediates the conjugation of Atg8 to phosphatidyl-
ethanolamine (Ichimura et al., 2000). The resulting products, 
Atg12–Atg5 and Atg8-phosphatidylethanolamine, are essential 
for proper autophagosome formation. Only a small fraction of 
the Atg12–Atg5 complex localizes at the autophagic isolation 
membrane throughout elongation, and the complex dissociates 
when the phagosome is complete. On the other hand, Atg8 
  remains on the mature autophagosome constituting the recog-
nized consensus marker of this structure. These two conjugation 
systems are highly conserved in mammalian cells. ATG5-
 defi  cient stem cells have been instrumental for demonstrating 
that the Atg12–Atg5 complex localizes at autophagosome pre-
cursors and plays an essential role in autophagosome formation 
(Mizushima et al., 2001). The production of ATG5-defi  cient 
mice has revealed that autophagy is required for neonatal 
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biquitously expressed micro- and millicalpain, 
which both require the calpain small 1 (CAPNS1) 
regulatory subunit for function, play important roles 
in numerous biological and pathological phenomena. 
We have previously shown that the product of GAS2, 
a gene speciﬁ  cally induced at growth arrest, is an inhibitor 
of millicalpain and that its overexpression sensitizes cells 
to apoptosis in a p53-dependent manner (Benetti, R., 
G. Del Sal, M. Monte, G. Paroni, C. Brancolini, and 
C. Schneider.  2001.  EMBO J. 20:2702–2714). More 
  recently, we have shown that calpain is also involved in 
nuclear factor κB activation and its relative prosurvival 
function in response to ceramide, in which calpain deﬁ  -
ciency strengthens the proapoptotic effect of ceramide 
(Demarchi, F., C. Bertoli, P.A. Greer, and C. Schneider. 
2005. Cell Death Differ. 12:512–522). Here, we further 
explore the involvement of calpain in the apoptotic switch 
and ﬁ  nd that in calpain-deﬁ  cient cells, autophagy is im-
paired with a resulting dramatic increase in apoptotic cell 
death. Immunostaining of the endogenous autophagosome 
marker LC3 and electron microscopy experiments demon-
strate that autophagy is impaired in CAPNS1-deﬁ  cient 
cells. Accordingly, the enhancement of lysosomal activity 
and long-lived protein degradation, which normally occur 
upon starvation, is also reduced. In CAPNS1-depleted 
cells, ectopic LC3 accumulates in early endosome-like 
  vesicles that may represent a salvage pathway for protein 
degradation when autophagy is defective.
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  survival before maternal feeding (Kuma et al., 2004). The anal-
ysis of endogenous LC3, which is one of the mammalian homo-
logues of Atg8, and the production of transgenic mice expressing 
a fl  uorescent autophagosomal LC3 have shown that the regula-
tion of autophagy is organ dependent and that the role of auto-
phagy is not restricted to the starvation response (Mizushima 
et al., 2004).
A pivotal role for autophagy in growth control has emerged 
from studies on Beclin1, the mammalian homologue of ATG6. 
The Beclin1 gene is deleted in several types of breast cancer 
that are unable to activate autophagy (Liang et al., 1999) and 
functions as a haploinsuffi  cient tumor suppressor gene (Yue 
et al., 2003). In addition to involvement in growth control, 
  programmed autophagy plays a role in differentiation (Ghidoni 
et al., 1996; Lee et al., 2002) and tissue remodeling (Rusten et al., 
2004). Moreover, autophagy may be artifi  cially induced by ra-
diation and treatment with certain drugs, including rapamycin 
(Noda and Ohsumi, 1998), ceramide (Scarlatti et al., 2004), 
  arsenic trioxide (Kanzawa et al., 2003), and tamoxifen (Bursch 
et al., 2000); the fi  nal outcome of such induction is still a matter 
of debate (Kroemer and Jaattela, 2005).
The calpain family of cysteine proteases is composed of 
both ubiquitous and tissue-specifi  c isoforms that share homol-
ogy in their protease domain and are calcium dependent (Goll 
et al., 2003). The best-characterized ubiquitous calpains are the 
isoforms μ- and m-calpain, which are also known as calpain 1 
and calpain 2, respectively. Both contain an 80-kD catalytic 
subunit and share a common 28-kD regulatory subunit com-
monly known as calpain 4 that is required for proper activity. 
Hereafter, calpain 4 will be referred to as calpain small 1 
(CAPNS1) in accordance with the nomenclature reported at the 
calpain website (http://ag.arizona.edu/calpains). A homologue 
to CAPNS1, CAPNS2, has been described previously (Schad 
et al., 2002). This protein appears to be a functional equivalent 
to CAPNS1 in vitro; however, its in vivo function and tissue 
distribution are still controversial. Interestingly, ubiquitous cal-
pains are associated with the endoplasmic reticulum and Golgi, 
a likely reservoir for autophagosome membranes (Hood et al., 
2004), where the essential autophagy regulatory complex 
PI3K–Beclin also localizes (Kihara et al., 2001).
Calpain is required for normal embryonic development. 
Indeed, the targeted disruption of CAPNS1 is embryonic lethal 
at days 10 and 11 as a result of severe defects in vascular devel-
opment (Arthur et al., 2000). Calpain is a regulator of adhesive 
complex dynamics in adherent cells (Bhatt et al., 2002); it plays 
an important role in osteoclastic bone resorption (Hayashi et al., 
2005) and is required for phagocytosis in human neutrophils 
(Dewitt and Hallett, 2002).
We have become interested in calpain function because of 
our observation that the product of GAS2, a gene specifi  cally 
induced at growth arrest, is in fact an inhibitor of millicalpain 
and that its overexpression sensitizes cells to apoptosis in a p53-
dependent manner (Benetti et al., 2001). More recently, we have 
shown that calpain is also involved in NF-κB activation and in 
its relative prosurvival function in response to ceramide, in 
which calpain defi  ciency strengthens the proapoptotic effect of 
ceramide (Demarchi et al., 2005). In this study, we further ex-
plore the involvement of calpain in the apoptotic switch and 
fi  nd that in calpain-defi  cient cells, autophagy is impaired with 
a resulting dramatic increase in apoptotic cell death.
Results
The lack of calpain activity is coupled 
to a block in autophagy
We have previously reported that calpain plays a crucial role in 
cell death regulation in response to ceramide. Indeed, we demon-
strated that the lack of calpain activity results in a considerable 
Figure 1.  CAPNS1
−/− MEFs lacking calpain 
activity are defective in autophagosome for-
mation. (A and B) Wild-type and CAPNS1
−/− 
MEFs were stimulated for 3 h with rapamycin 
or ceramide and analyzed by immunoﬂ  uores-
cence using an anti-LC3–speciﬁ  c antibody and 
PI to stain nuclei (A) or were lysed and used 
for Western blot analysis with the same anti-
body to detect both cytoplasmic LC3I and 
membrane-associated LC3II (B). Actin was 
used as a loading control. (B) The ratio be-
tween the intensities of LC3II and LC3I bands is 
indicated below each lane. Bar, 20 μm.
Figure 2.  CAPNS1 depletion is coupled to a block in autophagosome 
  formation in human cells. (A and B) U2OS cells were silenced with control 
siRNA or CAPNS1 siRNA and, 72 h later, were stimulated with ceramide 
for 3 h to trigger macroautophagy, as indicated in the ﬁ  gure. Afterward, 
the cells were ﬁ  xed and decorated with anti-LC3 and PI (A) or were lysed 
to perform Western analysis against endogenous LC3 (B). Actin was used 
as a loading control; anti-CAPNS1 antibody was used to check silencing 
efﬁ  ciency. (B) The ratio between the intensities of LC3II and LC3I bands is 
indicated below each lane. Bar, 20 μm.CALPAIN IS REQUIRED FOR MACROAUTOPHAGY • DEMARCHI ET AL. 597
increase in apoptotic cell death (Demarchi et al., 2005). To fur-
ther investigate the involvement of calpain in the modulation of 
alternative types of cell death, in this study, we address the role 
of calpain in autophagy. LC3 is the only available specifi  c 
marker to detect autophagosomes in mammalian cells (Kabeya 
et al., 2000).
 To directly tackle the question of whether calpain is re-
quired in autophagy, we analyzed endogenous LC3 in response 
to ceramide and rapamycin by means of immunofl  uorescence 
in wild-type and CAPNS1
−/− mouse embryonic fi  broblasts 
(MEFs). CAPNS1
−/− MEFs, which are also known as calpain 
4
−/− MEFs, were derived from CAPNS1 (calpain 4) knockout 
mice and were shown to lack calpain activity (Arthur et al., 
2000). Wild-type and CAPNS1
−/− MEFs were induced with 
each stimulus for 3 h or were left untreated. Afterward, the 
cells were fi  xed and subjected to immunofl  uorescence analysis 
with an anti-LC3 antibody. As shown in Fig. 1 A (top), wild-
type MEFs are faintly labeled by anti-LC3 antibody and show 
a clear induction of autophagosome formation after rapa-
mycin or ceramide treatment. On the other hand, CAPNS1
−/− 
MEFs show a higher diffuse background that does not sub-
stantially vary after stimulation with rapamycin or ceramide 
(Fig. 1 A, bottom).
In a parallel experiment, rapamycin and ceramide were 
used to stimulate wild-type and CAPNS1
−/− MEFs, and the 
  lysates were analyzed by Western blotting to detect both cyto-
plasmic LC3-I and its proteolytic derivative LC3-II that pref-
erentially associates with autophagosomal membranes (Kabeya 
et al., 2004). In agreement with the immunofl  uorescence data, 
both rapamycin and ceramide trigger an increase of LC3II with 
respect to LC3I in wild-type cells, whereas the ratio between 
the two LC3 forms is not considerably altered by both stimuli in 
CAPNS1
−/− MEFs (Fig. 1 B).
The fate of endogenous LC3 upon autophagy induction 
was also addressed in human U2OS cells. U2OS cells were 
transfected with a scrambled siRNA (siRNA control) or with a 
CAPNS1-specifi  c siRNA. 72 h later, autophagy was induced by 
a 3-h incubation with ceramide, and the cells were either fi  xed 
and analyzed by immunofl  uorescence or lysed and subjected to 
Western blot analysis. As shown in Fig. 2 A, CAPNS1 depletion 
prevents the formation of bona-fi  de autophagosomes upon in-
duction with ceramide. Accordingly, the increase in the endoge-
nous membrane-bound LC3II after ceramide treatment is clearly 
defective after CAPNS1 silencing (Fig. 2 B).
Calpain-deﬁ  cient cells show a defect 
in lysosomal activation and long-lived 
protein degradation
To further assess the requirement of calpain for the autophagic 
process, we followed the increase of lysosomal activity occurring 
Figure 3.  Lysosomal induction and long-lived protein degrada-
tion are hampered in CAPNS1-deﬁ  cient  MEFs.  Wild-type and 
CAPNS1 MEFs were incubated with the stimuli indicated, namely 
rapamycin (rapa), etoposide (ET), EBSS (EBS), serum-free medium 
(sf), and ceramide (cera), in the presence or absence of 3MA and 
were trypsinized, stained with LysoTracker green, and analyzed 
by FACS. (A–D) Representative FACS proﬁ  les obtained after Lyso-
Tracker staining of wild-type and CAPNS1
−/− MEFs before and 
after rapamycin treatment. The gate set between 10
1 and 10
2 
separates the cells with high ﬂ  uorescence from the background 
population. (E–G) The histograms report the percentage of cells 
with high LysoTracker staining and represent the mean values 
  obtained in four independent experiments. (H and I) Wild-type 
and CAPNS1
−/− MEFs were grown for 4 h in amino acid–free 
medium (H) or in serum-free medium (I) in the presence or absence 
of the autophagy inhibitor 3MA, and, subsequently, long-lived 
protein degradation was scored as the percentage of TCA-soluble 
counts on total radioactivity in a standard protein degradation 
  assay. The histograms report the mean values obtained in four inde-
pendent experiments. Error bars represent SD. SSC, side scatter.JCB • VOLUME 175 • NUMBER 4 • 2006  598
after autophagy induction by means of LysoTracker staining 
and FACS analysis. Wild-type and CAPNS1
−/− MEFs were 
  incubated with rapamycin for 24 h, trypsinized, stained with 
LysoTracker green, and analyzed by FACS. The results ob-
tained in a typical experiment are reported in Fig. 3 (A–D). 
A net increase in the percentage of cells that are highly labeled 
with LysoTracker occurs after rapamycin treatment of wild- 
type MEFs (Fig. 3 C) as compared with control untreated cells 
(Fig. 3 A), clearly showing that rapamycin results in an increase 
in lysosomal activity. On the contrary, in CAPNS1
−/− MEFs, 
rapamycin is ineffective in inducing an increase in LysoTracker 
fl  uorescence intensity (Fig. 3, compare B with D). The mean 
values of the percentage of cells highly labeled by LysoTracker 
obtained in four independent experiments are reported in Fig. 3 E. 
To determine whether the increase in lysosomal activity was 
dependent on macroautophagy induction, 3-methyladenine (3MA) 
was added just before stimulation with rapamycin. 3MA clearly 
inhibits the increase in LysoTracker staining, indicating the 
specifi  city of the induction (Fig. 3 E). Next, other autophagic 
stimuli, namely etoposide, starvation in Earle’s balanced salt 
solution (EBSS) or serum-free medium, and ceramide, were 
used to induce autophagy in wild-type and CAPNS1
−/− MEFs 
using the same type of assay. As shown in Fig. 3 F, all four 
stimuli induce autophagy-dependent lysosomal activation 
after 3 h in wild-type MEFs but not in CAPNS1
−/− MEFs; 
moreover, the increase in LysoTracker labeling is dramati-
cally reduced upon the addition of 3MA just before   induction 
(Fig. 3 G).
To further investigate the requirement of calpain in auto-
phagy, we monitored long-lived protein degradation upon amino 
acid starvation both in wild-type and CAPNS1
−/− MEFs ac-
cording to standard protocols (Pattingre et al., 2003). Amino 
acid starvation induces an increase in bulk protein degradation 
in both cell lines. However, such an increase is considerably 
lower in calpain-defi   cient cells as compared with wild-type 
cells (Fig. 3 H). A reduction in protein degradation occurs in the 
presence of the inhibitor 3MA in both cell lines, indicating that 
although considerably reduced, autophagy may still occur in 
CAPNS1
−/− MEFs as a consequence of amino acid starvation. 
Alternatively, this result might be caused by an effect of 3MA 
on alternative degradation pathways, as a similar effect is also 
observed in autophagy-defective ATG5
−/− cells (Mizushima 
et al., 2001). Similar results were obtained by studying long-lived 
protein degradation upon serum starvation (Fig. 3 I), confi  rming 
the importance of calpain in activating protein degradation 
through the autophagic process.
Calpain is required for autophagosome 
formation in response to rapamycin
Electron microscopy was used to directly analyze and quantify 
autophagosomes in wild-type and CAPNS1
−/− MEFs grown in 
control serum-containing medium and after autophagy induc-
tion with rapamycin or amino acid–free medium (EBSS). The 
morphology of early autophagic vacuole (AV [AVi]) and late AV 
(AVd) profi  les of wild-type MEFs are shown in Fig. 4 (A and B, 
respectively). The quantitative results obtained are represented 
in Fig. 4 C.
These electron microscopy experiments demonstrate that 
in CAPNS1
−/− MEFs, autophagosome formation is completely 
abolished in response to rapamycin. In the case of EBSS-
  induced autophagy, CAPNS1
−/− MEFs do show autophagosome 
formation but at a substantially reduced level compared with 
wild-type MEFs. In this last case, as shown in Fig. S2 (available 
at http://www.jcb.org/cgi/content/full/jcb.200601024/DC1), 
the morphology of the autophagosomes is not altered in 
CAPNS1
−/− MEFs with respect to wild-type MEFs. This led 
us to conclude that the mechanics of autophagosome forma-
tion are still functional in CAPNS1
−/− MEFs, however severely 
impaired in their effi  ciency. The diminished accumulation of 
autophagosomes in CAPNS1
−/− MEFs maintained in EBSS 
medium may therefore suggest that the dramatic reprogram-
ming of cell functions occurring upon amino acid deprivation 
may also involve the activation of some autophagic pathways 
not strictly requiring calpain function. Alternatively, because 
EBSS possibly represents a stronger and broader stimulus in 
respect to rapamycin, residual calpain activity caused by some 
other calpain isoforms may be suffi  cient to trigger autophagy, 
albeit at a reduced level.
This evidence prompted us to monitor Tor activity in both 
cell lines before and after rapamycin treatment using S6 kinase 
phosphorylation as readout. The results shown in Fig. S3 (avail-
able at http://www.jcb.org/cgi/content/full/jcb.200601024/DC1) 
clearly indicate that Tor is active in both cell lines, where it 
is inhibited with similar effi  ciency upon rapamycin addition. 
Figure 4.  Autophagosome formation is hampered in CAPNS1
−/− MEFs. 
(A and B) The electron micrographs show the ultrastructure of early (A) 
and late autophagosomes (B) in wild-type MEFs. The cell area on the 
grid squares was estimated by point counting using negatives taken at 
600×. (C) Quantiﬁ  cation of autophagosomes in wild-type and CAPNS1
−/− 
MEFs (knockout) grown in control serum-containing medium (FCS) or 
  induced for 3 h with EBSS (EBS) or rapamycin (Rap). Error bars indi-
cate  the SEM. The number of AVi and AVd proﬁ   les was counted 
under the   microscope at 12,000× from four to ﬁ  ve grid squares for 
each sample.CALPAIN IS REQUIRED FOR MACROAUTOPHAGY • DEMARCHI ET AL. 599
Further studies are required to defi  ne the key regulatory ele-
ments targeted by   calpain for the effi  cient induction of auto-
phagosome formation.
Ectopic LC3 constitutively forms discrete 
bodies in calpain-deﬁ  cient MEFs
A widely used method to study autophagy is monitoring the re-
distribution of the overexpressed autophagosome marker LC3 
from a mostly diffused localization to a punctuated pattern 
upon the addition of an autophagic stimulus. Therefore, in par-
allel to the studies on endogenous LC3, we monitored autopha-
gosome formation after overexpressed GFP-LC3 localization 
in wild-type and CAPNS1
−/− MEFs. 16 h after transfection, 
the cells were preincubated with the macroautophagy   inhibitor 
3MA or solvent alone, and ceramide was added for 3 h to 
  induce autophagy (Scarlatti et al., 2004). The cells were sub-
sequently fi  xed to analyze overexpressed LC3 by fl  uorescence 
microscopy. As shown in Fig. 5 A, in wild-type MEFs, LC3 
produces a mostly diffuse staining in the absence of stimulus 
and after 3MA treatment. After induction with ceramide, LC3 
accumulates in the autophagosomes, whose formation is pre-
vented by 3MA pretreatment, indicating the specifi  city of 
autophagy induction. However, in CAPNS1
−/− MEFs, LC3 
accumulates in specifi  c bodies even under basal conditions; 
  incubation with the autophagy inhibitor 3MA in this case does 
not prevent the formation of LC3 spots. In addition, the num-
ber of cells with intensely stained bodies does not substantially 
increase after the addition of ceramide (Fig. 5 B). Each exper-
iment was repeated at least four times, obtaining   reproducible 
results. For each experiment, the percentage of cells with LC3 
bodies was counted, and the mean value ± SD is reported in 
the fi  gure. At least 200 cells were analyzed for each indepen-
dent experiment.
To further monitor autophagy induction, wild-type and 
CAPNS1
−/− MEFs overexpressing GFP-LC3 were challenged 
with several stimuli that were previously used to induce auto-
phagy, namely rapamycin (Noda and Ohsumi, 1998), amino 
acid–free medium (Neely et al., 1977), serum starvation (Pfeifer, 
1973), and etoposide (Shimizu et al., 2004). All of the treat-
ments triggered autophagosome formation in wild-type MEFs 
(Fig. 5 C) while leaving unchanged the LC3 staining pattern in 
CAPNS1
−/− MEFs (not depicted). Altogether, these results fur-
ther suggest that autophagy is impaired in cells lacking calpain 
activity, where overexpressed LC3 constitutively accumulates 
into specifi  c bodies.
Calpain silencing is coupled 
to the accumulation of overexpressed 
LC3 in human cells
To verify whether the constitutive accumulation of ectopic LC3 
into the observed specifi  c bodies in CAPNS1
−/− MEFs was 
a peculiarity of the cell line used or a consequence of calpain in-
activation, we monitored the effect of calpain silencing by siRNA 
on autophagosome formation in the human osteosarcoma cell 
line U2OS. An ATG5-specifi  c siRNA that has been previously 
described (Boya et al., 2005) was used as a tool to prevent auto-
phagy, allowing the distinction between true autophagosomes 
and other undefi  ned structures containing ectopic LC3. U2OS 
cells were transfected with a scrambled siRNA (siRNA control) 
or with a CAPNS1-specifi  c siRNA in combination with ATG5 
siRNA or an ineffective siRNA as a control.
48 h later, the cells were transfected with GFP-LC3, and, 
after an additional 16 h, autophagy was induced by a 3-h incu-
bation with ceramide. The fi  xed cells were fi  nally analyzed by 
fl  uorescence microscopy. As shown in Fig. 6 A, LC3 appears 
diffuse in control U2OS cells and, after induction with cera-
mide, becomes associated with autophagosomes, which are not 
formed by specifi   cally inhibiting autophagy through ATG5 
siRNA. On the other hand, CAPNS1-silenced U2OS cells show 
LC3-positive bodies in the absence of stimulation, and the 
  distribution of GFP-LC3 is not altered by ATG5 silencing. In 
  addition, the LC3 staining pattern is not considerably affected 
by ceramide (Fig. 6 B).
To mark and analyze the LC3 pattern specifi  cally in the 
cells where CAPNS1 is silenced, we developed an siCAPNS1-
GFP p-superior plasmid (siCAPNS1-GFP) allowing the simul-
taneous expression of CAPNS1 siRNA and GFP. In parallel, we 
produced a U2OS-derivative cell line expressing HcRed-LC3 
(U2OS-LC3) as a tool to study autophagy induction. U2OS-
LC3 cells were transfected with a control vector (sicontrol-GFP) 
or with siCAPNS1-GFP plasmid; after 48 h, they were stimu-
lated or left unstimulated with ceramide for 3 h and were fi  xed 
and analyzed by fl  uorescence microscopy.
As shown in Fig. 6 C, in the cells transfected with the 
control plasmid, HcRed-LC3 appears diffuse before induc-
tion and forms autophagosomes after ceramide treatment as 
  expected. However, siCAPNS1-GFP–transfected cells show a 
punctuated LC3 pattern both in the presence and absence of ce-
ramide stimulation. Collectively, the data obtained in U2OS cells 
are in agreement with the data obtained comparing wild-type 
Figure 5.  Ectopic LC3 constitutively accumulates in vesicles in CAPNS1
−/− 
MEFs. (A–C) Wild-type (A and C) and CAPNS1
−/− MEFs (B) were trans-
fected with GFP-rLC3, and, 16 h later, the cells were treated for 3 h with 
the stimuli indicated. Afterward, the cells were ﬁ  xed and analyzed by ﬂ  uo-
rescence microscopy. Representative ﬁ  elds are shown. The different pat-
terns of GFP-LC3 distribution were scored in 250 transfected cells for at 
least three independent experiments. The mean of the percentage of cells 
with intensely stained bodies and relative SD are indicated beneath each 
image. Bar, 20 μm.JCB • VOLUME 175 • NUMBER 4 • 2006  600
with CAPNS1
−/− MEFs, demonstrating that in CAPNS1-
  depleted cells, overexpressed LC3 accumulates in specifi  c 
bodies independently of autophagy induction.
Ectopic LC3 bodies constitutively present 
in CAPNS1-depleted cells are enriched 
in endosome markers
To investigate the identity of LC3-containing structures in 
CAPNS1-depleted cells, we analyzed whether overexpressed 
LC3 would eventually colocalize with specifi  c endosomal mark-
ers both in control and in CAPNS1-silenced U2OS-LC3 cells. 
48 h after silencing with control or CAPNS1 siRNA, autophagy 
was induced by ceramide together with pepstatin to inhibit lyso-
somal activity and freeze any eventual transient colocalization 
event. Thereafter, the cells were fi  xed and subjected to immuno-
fl  uorescence against the markers LAMP-2, EEA1, and trans-
ferrin receptor and were analyzed by a confocal microscope. 
Representative images are shown in Fig. 7. The colocalization 
of LC3 with the endosomal markers was quantifi  ed using ImageJ 
software (colocalizer plug-in). The Pearson correlation coeffi  -
cient (R) is reported near each merged image. Altogether, the 
data indicate that overexpressed LC3 bodies are enriched in 
  endosome markers specifi  cally in calpain-depleted cells.
To precisely defi  ne the identity of the LC3-positive bod-
ies that accumulate in calpain-defi  cient cells, immunoelectron 
  microcopy studies were performed. U2OS cells were trans-
fected with GFP-LC3 and siRNA specifi  c for CAPNS1 as 
  described in the fi  rst section of Results and were fi  xed in PFA. 
Double labeling with GFP and LAMP-2 antibodies allowed 
us to detect GFP-LC3 bodies and also mark endosomes in the 
same experiment. As expected, GFP-LC3 partly accumulates in 
specifi  c bodies, as shown in Fig. 8 (A and B). The gold par-
ticles indicating the presence of GFP-LC3 bodies (Fig. 8, large 
gold dots) were associated with endosome-like structures, 
some of which were also positive for LAMP-2 (Fig. 8; small 
gold dots are indicated by arrowheads). The morphology and 
LAMP-2 labeling pattern of GFP-LC3 structures corresponded 
to that of early endosome-like vesicles, clearly confi  rming that 
GFP-LC3 bodies accumulating in CAPNS1-depleted cells are 
not autophagosomes.
Figure 6.  Ectopic LC3 forms speciﬁ  c bodies in CAPNS1-depleted human 
cells. (A and B) U2OS cells were silenced with a control siRNA (A) or with 
a CAPNS1 siRNA (B) in combination with a control siRNA or ATG5 siRNA 
as indicated. After 48 h, the cells were transfected with GFP-hLC3 and, 16 h 
later, were incubated for 3 h with ceramide or solvent alone as a negative 
control. They were subsequently ﬁ   xed and analyzed by ﬂ   uorescence 
  microscopy. Representative ﬁ  elds are shown. (C and D) A U2OS-derivative 
cell line stably expressing HcRed-hLC3 (U2OS-LC3) was established. 
U2OS-LC3 cells were transfected with si-control-GFP (C) or siCAPNS1-GFP (D) 
expression vectors and, 48 h later, were either treated with ceramide 
or with solvent alone for 3 h as indicated. Finally, the cells were ﬁ  xed and 
analyzed by ﬂ  uorescence microscopy. The different patterns of GFP-LC3 
distribution were scored in 250 transfected cells for at least three indepen-
dent experiments. Bar, 20 μm.
Figure 7.  Ectopic LC3 bodies are enriched with endosome markers in 
CAPNS1-depleted cells. (A–C) U2OS-LC3 cells were silenced with a control 
siRNA or a CAPNS1 siRNA as indicated and, 48 h later, were stimulated 
for 3 h with ceramide to induce macroautophagy. Pepstatin A was added 
to inhibit lysosomal activity and freeze any colocalization event between 
LC3 vesicles and lysosomes. Subsequently, the cells were ﬁ  xed, decorated 
with anti–LAMP-2 (A), anti-EEA1 (B), and antitransferrin receptor (TR; C), 
and analyzed by confocal microscopy. Images of representative ﬁ  elds 
were taken. The Pearson’s correlation coefﬁ  cient, R, is reported for each 
merge image. Bars, 20 μm.CALPAIN IS REQUIRED FOR MACROAUTOPHAGY • DEMARCHI ET AL. 601
The calpain-dependent impairment 
of autophagy sensitizes cells to apoptosis
We have previously reported that ceramide triggers apoptosis 
and induces an NF-κB–dependent prosurvival pathway through 
calpain. Accordingly, in calpain-defi  cient cells, apoptosis is 
  enhanced (Demarchi et al., 2005). In this study, we have demon-
strated that calpain is required to induce autophagy in response 
to ceramide, etoposide, and amino acid or serum starvation. 
  Recent studies indicate the existence of a negative cross-regulation 
between autophagy and apoptosis (Yu et al., 2004; Boya et al., 
2005; Takacs-Vellai et al., 2005). However, there are examples 
of a mutual requirement between the two pathways (Camougrand 
et al., 2003; Martin and Baehrecke, 2004). Therefore, we 
  decided to defi  ne the effect of the calpain-related autophagy 
block on apoptosis induction in the cellular systems used for 
this study.
Wild-type and CAPNS1
−/− MEFs were incubated with 
the autophagy inducers etoposide, ceramide, serum-free me-
dium, EBSS, or vinblastine for 20 h. Afterward, the cells were 
double labeled with annexin V and propidium iodide (PI) and 
were analyzed by FACS. The results obtained in a typical ex-
periment of EBSS induction are reported in Fig. 9 (A–D). The 
histogram presented in Fig. 9 E summarizes the results of four 
independent experiments for each specifi  c stimulus. A dramatic 
increase in apoptosis can be seen in calpain-defi  cient cells after 
induction with all of the stimuli, with the exception of vinblastine. 
Vinblastine is a microtubule-depolymerizing agent, and, although 
it can trigger an autophagic response, it has inhibitory functions 
on late autophagic events (Punnonen and Reunanen, 1990). 
  Interestingly, we have previously reported that the toxicity of 
taxol, an indirect inhibitor of autophagy by virtue of its block of 
microtubule depolymerization, is almost comparable in wild-type 
and CAPNS1
−/− MEFS (Demarchi et al., 2005). Collectively, 
the aforementioned data highlight the cytoprotective potential 
of autophagy in MEFs and strongly argue for a strict correlation 
between the impairment of autophagy in   calpain-defi  cient cells 
and induction of the apoptotic switch.
To further confi  rm this hypothesis, a similar approach was 
followed using human U2OS cells silenced either with ATG5, 
CAPNS1-specifi  c siRNA, or a combination of the two. 48 h af-
ter silencing, the cells were shifted to amino acid–free medium 
and incubated for a further 20 h to trigger autophagy. Cell death 
was then quantifi  ed by means of PI and annexin staining fol-
lowed by FACS analysis. Fig. 10 (A–F) presents the results of 
a representative experiment and indicates that both ATG5 and 
CAPNS1 silencing sensitize U2OS cells to apoptosis induced 
by amino acid starvation. The mean values obtained in four in-
dependent experiments are reported in Fig. 10 G. The effect of 
CAPNS1 silencing is the most severe, suggesting that CAPNS1 
depletion in addition to the block of autophagy also prevents 
other antiapoptotic mechanisms such as NF-κB activation 
(Demarchi et al., 2005).
Discussion
In this study, we demonstrate that calpain regulates macroauto-
phagy in two cellular systems lacking calpain activity: MEFs 
derived from CAPNS1 knockout mice and CAPNS1-silenced 
Figure 8.  GFP-LC3 bodies in CAPNS1-depleted cells are 
  endosome-like structures. Representative immunoelectron micro-
scopy micro  photographs showing the ultrastructure of GFP-LC3 
bodies in CAPNS1-depleted U2OS cells. Large gold dots mark 
GFP-positive structures, whereas small gold dots (indicated by 
arrowheads) are labeled with anti–LAMP-2.
Figure 9. CAPNS1
−/− MEFs are more sensitive to apoptosis. (A–D) Wild-
type and CAPNS1
−/− MEFs were treated with etoposide (ET), ceramide 
(cera), EBSS, serum-free medium (sf), and vinblastine (vin) or left in control 
medium (cont) for 20 h and stained with PI and annexin V–FITC. A set of 
representative experiments with EBSS is shown. The cells in the bottom right 
quadrant were scored as apoptotic. (E) The mean values obtained in four 
independent experiments with all of the stimuli. Error bars represent SD.JCB • VOLUME 175 • NUMBER 4 • 2006  602
human cells. In addition, we shed some light on the relationship 
between apoptosis and autophagy.
Calpains are activated by several stimuli that trigger macro-
autophagy, including starvation (Gomez-Vicente et al., 2005), 
ceramide (Tanabe et al., 1998; Demarchi et al., 2005), etoposide 
(Varghese et al., 2001), and arsenic trioxide ( Karlsson et al., 
2004). Milli- and microcalpain, which both require CAPNS1 for 
activity, are localized at the endoplasmic reticulum and Golgi, 
where the autophagic machinery works (Kihara et al., 2001; 
Pattingre et al., 2005).
In both calpain-null systems used in this study, defi  cient 
autophagy was shown by four different approaches: analysis of 
exogenous and endogenous LC3 by immunofl  uorescence and 
Western blotting, quantifi  cation of lysosomal induction, long-
lived protein degradation assays, and electron microscopy. 
  Altogether, the data presented indicate that in CAPNS1-defi  cient 
cells, the autophagic program is not effi  ciently activated. As a 
result of this defect, CAPNS1-defi  cient cells are more sensitive 
to apoptosis induced by several autophagic stimuli, including 
ceramide, etoposide, and starvation.
In light of our fi  ndings connecting calpain and auto  phagy, 
it will be interesting to investigate this relationship in vivo 
under physiological and pathological conditions as well as in 
response to chemotherapy. Previously reported data lend sup-
port to such a possibility. The dual role of autophagy has been 
seen during cancer progression, where, at the initial stages, auto-
phagy prevents tumor growth (Liang et al., 1999), whereas at 
advanced stages, it might favor tumor cell survival (Paglin et al., 
2001). An example of this is calpain 9, which appears to be a 
  tumor suppressor of gastric cancer, whereas calpain activation 
has been shown to be involved in cell transformation and invasion 
(Carragher and Frame, 2002; Xu and Deng, 2004).
Most interestingly, this parallel is maintained in other 
  degenerative pathologies. Autophagy is protective during the 
initial stages of neurodegeneration (Webb et al., 2003; Ravikumar 
et al., 2004), whereas it becomes deleterious at later stages (Yue 
et al., 2002). A similar dual role could be played by calpain in 
neuronal diseases, where it may be protective at the initial stages 
of neurodegeneration (Kim et al., 2003) and   hyperactivated and 
detrimental at advanced stages (Park and Ferreira, 2005). A de-
tailed investigation of the molecular cross talk between these 
two systems in living organisms might be instrumental for per-
forming appropriate strategies of mole  cular intervention.
The precise molecular network linking autophagy, apop-
tosis, and other types of cell death is still unresolved (Assuncao 
Guimaraes and Linden, 2004; Kroemer and Jaattela, 2005). 
  Autophagy is protective against low radiation damage (Paglin 
et al., 2001) and against mutant huntingtin-induced cell death 
(Bjorkoy et al., 2005); it is essential for maintaining cell 
  survival after growth factor withdrawal in Bax
−/−Bak
−/− cells 
(Lum et al., 2005). Furthermore, the inhibition of macroauto-
phagy triggers apoptosis (Boya et al., 2005; Gonzalez-Polo 
et al., 2005). On the other hand, autophagy is coupled to cell 
death in Bax
−/−Bak
−/− MEFs (Shimizu et al., 2004) and in 
tamoxifen-treated MCF7 cells (Bursch et al., 2000). In addition, 
autophagy and apoptosis are positively interconnected in sev-
eral systems, including Drosophila development (Baehrecke, 
2003), rat retinal tissue development (Guimaraes et al., 2003), 
and peripheral nerves of adult rats after damage (Xue et al., 
1999). Collectively, our data further support the argument that 
macroautophagy is a survival strategy activated both in response 
to serum and amino acid deprivation. In addition, we have 
shown that macroautophagy is activated and also plays a protec-
tive role upon treatment with specifi  c drugs, such as etoposide 
and ceramide; thus, the knockdown of autophagy could be a 
strategy for improving chemotherapy protocols.
Ectopic LC3 is a powerful tool to study autophagy 
  (Kabeya et al., 2000). In this study, we confi  rmed that in MEFs 
and U2OS human osteosarcoma cells, the formation of LC3 
  autophagosomes is effi  ciently inhibited by treatment with the 
  autophagy inhibitor 3MA and by siRNA-mediated depletion of 
the essential autophagy gene ATG5, respectively. However, in 
CAPNS1
−/− MEFs and siCAPNS1-depleted cells, we observed 
that ectopic LC3 constitutively accumulates in the absence of 
any specifi  c autophagic stimulus into cytoplasmic endosome-
like bodies enriched with endosomal markers. Therefore, we 
hypothesize that such LC3 bodies could represent a default 
or  salvage lysosomal pathway for protein degradation with 
slower clearance kinetics, which becomes manifest in a calpain-
 defi  cient cellular context. A similar pathway may be predicted 
for the endogenous proteins that accumulate in diseases coupled 
to autophagy defects.
Figure 10.  Depletion of CAPNS1 results in increased apoptosis in human 
cells. U2OS cells were transfected with a siRNA speciﬁ  c  for  CAPNS1, 
ATG5, or a combination of the two. An ineffective siRNA was used as a 
negative control. 48 h later, the cells were shifted to amino acid–free me-
dium for an additional 20 h, stained with PI and annexin-FITC, and ana-
lyzed by FACS. (A–F) Results of a set of representative experiments. (G) The 
mean of the values obtained in four independent experiments. Bars indi-
cate the percentage of annexin-positive cells with high (h) PI staining (top 
right quadrant in A–F) and low (l) PI staining (bottom right quadrant in A–F). 
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Further studies are required to analyze the detailed mech-
anisms involving calpains in the formation of autophagosomes 
and in lysosomal-mediated protein degradation pathways. 
Given the strategic localization of milli- and microcalpain at 
the endoplasmic reticulum, it would be tempting to speculate 
that calpain may play a role in the delivery of membranes to 
the autophagosome. Alternatively, calpain could modulate one 
or more key components of the signaling networks, ultimately 
leading to autophagosome formation. The complete block 
of autophagosome formation occurring in rapamycin-treated 
CAPNS1
−/− MEFs favors such a possibility.
Materials and methods
Chemicals and reagents
C2 ceramide, baﬁ  lomycin, pepstatin A, 3MA, rapamycin, and etoposide 
were purchased from Sigma-Aldrich. LipofectAMINE reagent and Oligo-
fectamine were purchased from Invitrogen. SMARTpool for CAPNS1 si-
lencing was obtained from Dharmacon. Micro- and millicalpain siRNAs 
were purchased from Santa Cruz Biotechnology, Inc.
Plasmids and constructs
HcRed-hLC3 and pGFP-hLC3 were constructed by inserting human LC3 in 
HcRed and pGFP plasmid, respectively. The plasmid pGFP-rLC3 was a gift 
from T. Yoshimori (National Institute of Genetics, Shizuoka, Japan). The 
plasmid siCapns1-GFP was obtained by subcloning a double-stranded 
  oligonucleotide containing a sequence complementary to CAPNS1 siRNA 
into commercial p-superior–GFP plasmid according to the manufacturer’s 
instructions. All constructs were checked by sequence analysis.
Cell culture
Wild-type and CAPNS1
−/− MEFs (Dourdin et al., 2001) were gifts from 
P.A. Greer (Queen’s University, Kingston, Ontario, Canada). U2OS cells 
and the aforementioned mouse ﬁ   broblasts were grown in DME supple-
mented with 10% FCS.
Immunological procedures and quantiﬁ  cations
Standard protocols for immunoblotting and immunoﬂ   uorescence were 
used. Rabbit serum raised against LC3 was provided by T. Yoshimori. 
Monoclonal antibody against LAMP-2 was purchased from BD   Biosciences. 
LAMP-1–speciﬁ  c antibody was purchased from Santa Cruz   Biotechnology, 
Inc., and monoclonal anti-CAPNS1 was purchased from Sigma-Aldrich. 
Monoclonal antitransferrin receptor (OKT9) was previously described 
(Sutherland et al., 1981). Band quantiﬁ   cation from Western blots was 
performed using the Image 1.63.sea program (Scion). Secondary anti-
bodies for immunoﬂ  uorescence were FITC conjugated, and the cells were 
mounted using Mowiol medium. Analysis and acquisition were performed 
using a confocal laser-scanning microscope (Axiovert 100 M; Carl Zeiss 
MicroImaging, Inc.) with a 63× NA 1.25 or 100× NA 1.30 oil objec-
tive (Leica) at room temperature. Images were imported using LSM-510 
software (Carl Zeiss MicroImaging, Inc.). ImageJ software (National 
  Institutes of Health) was used to quantify the colocalization observed 
by immunoﬂ  uorescence.
Transfection
Stable transfections of U2OS cells with HcRed-LC3 were performed by the 
calcium phosphate method using standard procedures. U2OS, CAPNS1
−/−, 
and control mouse ﬁ   broblasts at 60–80% conﬂ   uency were transiently 
transfected or oligofected using FuGene (Roche) or Oligofectamine (Life 
Technologies) according to the manufacturer’s instructions.
Statistical analysis
Results are expressed as means ± SD of at least three independent experi-
ments performed in triplicate or quadruplicate unless indicated otherwise. 
Statistical analysis was performed using a t test, with the level of signiﬁ  -
cance set at P < 0.05.
LysoTracker labeling and quantiﬁ  cation
To label lysosomes, LysoTracker green (Invitrogen) was used at a ﬁ  nal con-
centration of 75 nM. The cells induced for 3 or 24 h with the stimuli were 
trypsinized, resuspended in phenol-free DME, 10% FCS, and 75 nM Lyso-
Tracker green, incubated for 30 min at 37°C, and analyzed with the Cell-
Quest program (BD Biosciences) by FacsCalibur (Becton Dickinson).
Protein degradation assay
Cells were labeled in complete medium in the presence of [
14C]valine for 
18 h, washed, and incubated with cold medium for 1 h to allow the degra-
dation of short-lived proteins. Then, after extensive washing, the medium 
was replaced with EBSS for 4 h in the presence or absence of 10 mM 
3MA. Finally, the proteins were precipitated with TCA, and radioactivity 
was measured. Protein degradation was calculated as the percentage of 
TCA-soluble counts on total radioactivity.
Electron microscopy
Monolayers were ﬁ  xed in 2% glutaraldehyde in 0.2 M Hepes, pH 7.4, for 
2 h and were scraped off the dish during ﬁ  xation. The pellets were embed-
ded in Epon using routine procedures. Approximately 60-nm sections were 
cut and stained using uranyl acetate and lead citrate and were examined 
with an electron microscope (JEM 1200EXII; JEOL). The number of AVi and 
AVd proﬁ  les was counted under the microscope by systematically screen-
ing the sections at 12,000× using grid squares as sampling units, as previ-
ously described (Eskelinen et al., 2004).
All AVs occurring in the grid were recorded. The area of cells on 
each grid square was estimated by point counting using photographic 
negatives taken at 600×. Four to ﬁ  ve grid squares were screened for each 
sample. The number of vacuoles per cell area was then counted for each 
grid square separately.
For immunogold electron microscopy, U2OS cells were ﬁ  xed in 4% 
PFA in 0.2 M Hepes, pH 7.4, for 2 h at room temperature and were further 
processed as previously described (Eskelinen et al., 2002). The cell sec-
tions were analyzed by immunogold electron microscopy with rabbit 
anti-GFP and mouse anti–LAMP-2 antibodies followed by the secondary 
antibodies goat anti–rabbit conjugated to 10 nm gold and goat anti–mouse 
coupled to 5 nm gold.
Annexin V and PI staining and FACS analysis
Translocation of phosphatidylserine to the cell surface was monitored by 
using an annexin V–FITC apoptosis detection kit (Sigma-Aldrich). Cells 
were trypsinized, washed in PBS, and resuspended in binding buffer 
(10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl, and 2.5 mM CaCl2). Cell 
density was adjusted to 2–5 × 10
5 cells/ml. 1 μl of recombinant human 
annexin V–FITC/a and 2 μl PI were added to 100 μl of cell suspension; 
the mixture was brieﬂ  y mixed and incubated for 10 min at room tempera-
ture in the dark. Afterward, 400 μl of binding buffer was added to the cells 
that were then analyzed by FACScan (Becton Dickinson). 15,000 events 
were collected in list mode fashion, stored, and analyzed by CellQuest 
software (BD Biosciences).
Online supplemental material
Fig. S1 shows that the depletion of microcalpain impairs   macroauto  phagy. 
Fig. S2 shows that the ﬁ   ne ultrastructure of autophagosomes is not al-
tered in CAPNS1
−/− MEFs. Fig. S3 shows that rapamycin inhibits Tor 
activity in wild-type and CAPNS1
−/− MEFs. Fig. S4 shows that LC3II is 
associated with membranes in CAPNS1
−/− MEFs. Fig. S5 shows that 
the induction of LysoTracker-labeled bodies is reduced in CAPNS1
−/− MEFs. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200601024/DC1.
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